Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rajesh Tim Gandhi, M.D.

Other Positions

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. G08LM008830 (GANDHI, RAJESH T) Jun 1, 2007 - Nov 30, 2011
    eMicrobes: A Digital Library for Learning Infectious Diseases
    Role: Principal Investigator
  2. R01AI066992 (GANDHI, RAJESH T) Jan 1, 2006 - Dec 31, 2012
    Induction of HIV-specific Immune Responses
    Role: Principal Investigator
  3. P30AI060354 (GANDHI, RAJESH T) Jul 1, 2004 - Jul 31, 2024
    Harvard University Center for AIDS Research
    Role: Co-Principal Investigator
  4. K08AI001443 (GANDHI, RAJESH T) Sep 1, 1997 - Dec 31, 2003
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Scully EP, Aga E, Tsibris A, Archin N, Starr K, Ma Q, Morse GD, Squires KE, Howell BJ, Wu G, Hosey L, Sieg SF, Ehui L, Giguel F, Coxen K, Dobrowolski C, Gandhi M, Deeks S, Chomont N, Connick E, Godfrey C, Karn J, Kuritzkes DR, Bosch RJ, Gandhi RT. Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial. Clin Infect Dis. 2022 Oct 12; 75(8):1389-1396. PMID: 35176755; PMCID: PMC9555843.
    Citations:    Fields:    
  2. Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VCC, Edwards KM, Gallagher JC, Gandhi RT, Muller WJ, Nakamura MM, O'Horo JC, Shafer RW, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2022 Sep 05. PMID: 36063397; PMCID: PMC9494372.
    Citations: 10     Fields:    
  3. Ward AR, Thomas AS, Stevenson EM, Huang SH, Keating SM, Gandhi RT, McMahon DK, Bosch RJ, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Jones RB. No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART. AIDS. 2022 10 01; 36(12):1617-1628. PMID: 35730388; PMCID: PMC9444951.
    Citations:    Fields:    
  4. Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes I, Patel R, Gainer L, Dutton L, Donahue E, Gandhi RT, Baden LR, Woolley AE. Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system. medRxiv. 2022 Jun 17. PMID: 35734084; PMCID: PMC9216724.
  5. Bosch RJ, Gandhi RT, Mar H, Eron JJ, Cyktor JC, McMahon DK, Mellors JW. Associations Between Multiple Measures of HIV-1 Persistence in Persons on Suppressive Antiretroviral Therapy. J Infect Dis. 2022 06 15; 225(12):2163-2166. PMID: 35137129; PMCID: PMC9200144.
    Citations:    Fields:    Translation:HumansCells
  6. Gandhi RT, Malani PN, Del Rio C. COVID-19 Treatments for Nonhospitalized Patients-Reply. JAMA. 2022 06 14; 327(22):2248. PMID: 35699707.
    Citations:    Fields:    Translation:HumansCells
  7. Cyktor JC, Bosch RJ, Mar H, Macatangay BJ, Collier AC, Hogg E, Godfrey C, Eron JJ, McMahon DK, Mellors JW, Gandhi RT. Reply to Bottanelli et al. J Infect Dis. 2022 06 01; 225(11):2051-2052. PMID: 35381084.
    Citations:    Fields:    
  8. Villalba JA, Maus MV, Frigault MJ, Zaffini R, Gandhi RT, Rosenberg ES, Siedner MJ. False-Positive Human Immunodeficiency Virus Test Results in Patients Receiving Lentivirus-Based Chimeric Antigen Receptor T-Cell Therapy: Case Report, Review of the Literature, and Proposed Recommendations. J Infect Dis. 2022 06 01; 225(11):1933-1936. PMID: 34927686.
    Citations:    Fields:    Translation:HumansCells
  9. Sendi P, Razonable RR, Nelson SB, Soriano A, Gandhi RT. First-generation oral antivirals against SARS-CoV-2. Clin Microbiol Infect. 2022 Sep; 28(9):1230-1235. PMID: 35545195; PMCID: PMC9080050.
    Citations:    Fields:    
  10. Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi RT, Gallagher JC, Muller WJ, O'Horo JC, Shoham S, Wollins DS, Falck-Ytter Y. Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords. Clin Infect Dis. 2022 05 03; 74(9):1686-1690. PMID: 34668010; PMCID: PMC8574541.
    Citations:    Fields:    Translation:HumansPHPublic Health
  11. Bhimraj A, Morgan RL, Shumaker AH, Baden L, Chi-Chung Cheng V, Edwards KM, Gandhi RT, Gallagher JC, Muller WJ, O'Horo JC, Shoham S, Wollins DS, Falck-Ytter Y. Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel. Clin Infect Dis. 2022 05 03; 74(9):1691-1695. PMID: 34668008; PMCID: PMC8574532.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  12. Dubé K, Eskaf S, Barr L, Palm D, Hogg E, Simoni JM, Sugarman J, Brown B, Sauceda JA, Henley L, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 2022 06; 38(6):510-517. PMID: 35323030; PMCID: PMC9225827.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  13. Gaebler C, Nogueira L, Stoffel E, Oliveira TY, Breton G, Millard KG, Turroja M, Butler A, Ramos V, Seaman MS, Reeves JD, Petroupoulos CJ, Shimeliovich I, Gazumyan A, Jiang CS, Jilg N, Scheid JF, Gandhi R, Walker BD, Sneller MC, Fauci A, Chun TW, Caskey M, Nussenzweig MC. Prolonged viral suppression with anti-HIV-1 antibody therapy. Nature. 2022 06; 606(7913):368-374. PMID: 35418681; PMCID: PMC9177424.
    Citations:    Fields:    Translation:HumansCells
  14. Li JZ, Aga E, Bosch RJ, Pilkinton M, Kroon E, MacLaren L, Keefer M, Fox L, Barr L, Acosta E, Ananworanich J, Coombs R, Mellors JW, Landay AL, Macatangay B, Deeks S, Gandhi RT, Smith DM. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Clin Infect Dis. 2022 03 09; 74(5):865-870. PMID: 34117753; PMCID: PMC8906742.
    Citations: 5     Fields:    Translation:Humans
  15. Gandhi RT, Malani PN, Del Rio C. COVID-19 Therapeutics for Nonhospitalized Patients. JAMA. 2022 02 15; 327(7):617-618. PMID: 35029659.
    Citations: 2     Fields:    Translation:Humans
  16. Bender Ignacio RA, Gandhi RT. COVID-19: Where We Are, Where We Need to Be. Infect Dis Clin North Am. 2022 06; 36(2):xiii-xv. PMID: 35636911; PMCID: PMC8831136.
    Citations:    Fields:    Translation:Humans
  17. Ivison GT, Vendrame E, Martínez-Colón GJ, Ranganath T, Vergara R, Zhao NQ, Martin MP, Bendall SC, Carrington M, Cyktor JC, McMahon DK, Eron J, Jones RB, Mellors JW, Bosch RJ, Gandhi RT, Holmes S, Blish CA. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients. Front Cell Infect Microbiol. 2022; 12:757846. PMID: 35223535; PMCID: PMC8866573.
    Citations:    Fields:    Translation:HumansCells
  18. Sari H, Galbusera R, Bonnier G, Lin Y, Alshelh Z, Torrado-Carvajal A, Mukerji SS, Ratai EM, Gandhi RT, Chu JT, Akeju O, Orhurhu V, Salvatore AN, Sherman J, Kwon DS, Walker B, Rosen B, Price JC, Pollak LE, Loggia M, Granziera C. Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers. Neurol Neuroimmunol Neuroinflamm. 2022 03; 9(2). PMID: 35140142; PMCID: PMC8860468.
    Citations: 3     Fields:    Translation:Humans
  19. Li JZ, Gandhi RT. Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management. JAMA. 2022 02 01; 327(5):427-429. PMID: 35029644.
    Citations: 3     Fields:    Translation:HumansCells
  20. Moldt B, Günthard HF, Workowski KA, Little SJ, Eron JJ, Overton ET, Lehmann C, Rokx C, Kozal MJ, Gandhi RT, Braun DL, Parvangada A, Li J, Martin R, Selzer L, Cox S, Margot N, Liu H, Slamowitz D, Makadzange T, Collins SE, Geleziunas R, Callebaut C. Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals. AIDS. 2022 02 01; 36(2):205-214. PMID: 34586088.
    Citations:    Fields:    Translation:HumansCells
  21. Chen J, Titanji K, Sheth AN, Gandhi R, McMahon D, Ofotokun I, Weitzmann MN, De Paris K, Dumond JB. The effect of age on CD4+ T-cell recovery in HIV-suppressed adult participants: a sub-study from AIDS Clinical Trial Group (ACTG) A5321 and the Bone Loss and Immune Reconstitution (BLIR) study. Immun Ageing. 2022 Jan 03; 19(1):4. PMID: 34980186.
  22. Connors JM, Iba T, Gandhi RT. Thrombosis and Coronavirus Disease 2019: Controversies and (Tentative) Conclusions. Clin Infect Dis. 2021 12 16; 73(12):2294-2297. PMID: 33539504.
    Citations: 2     Fields:    Translation:HumansCells
  23. Gandhi RT. The Multidimensional Challenge of Treating Coronavirus Disease 2019 (COVID-19): Remdesivir Is a Foot in the Door. Clin Infect Dis. 2021 12 06; 73(11):e4175-e4178. PMID: 32735655.
    Citations: 8     Fields:    Translation:HumansCells
  24. Reynolds Z, McCluskey SM, Moosa MYS, Gilbert RF, Pillay S, Aturinda I, Ard KL, Muyindike W, Musinguzi N, Masette G, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson BA, Gandhi RT, Sunpath H, Marconi VC, Bwana MB, Siedner MJ. Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa. HIV Med. 2022 05; 23(5):474-484. PMID: 34755438; PMCID: PMC9010349.
    Citations:    Fields:    Translation:Humans
  25. Kim AY, Gandhi RT. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around. Clin Infect Dis. 2021 11 02; 73(9):e3009-e3012. PMID: 33035308.
    Citations: 7     Fields:    Translation:HumansCells
  26. Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Hecht FM, Li JZ. Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. AIDS. 2021 11 01; 35(13):2225-2227. PMID: 34127579; PMCID: PMC8490281.
    Citations: 2     Fields:    Translation:Humans
  27. Siedner MJ, Moosa MS, McCluskey S, Gilbert RF, Pillay S, Aturinda I, Ard K, Muyindike W, Musinguzi N, Masette G, Pillay M, Moodley P, Brijkumar J, Rautenberg T, George G, Gandhi RT, Johnson BA, Sunpath H, Bwana MB, Marconi VC. Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial. Ann Intern Med. 2021 12; 174(12):1683-1692. PMID: 34698502; PMCID: PMC8688215.
    Citations:    Fields:    Translation:Humans
  28. Dryden-Peterson S, Velásquez GE, Stopka TJ, Davey S, Gandhi RT, Lockman S, Ojikutu BO. Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts. JAMA Health Forum. 2021 09; 2(9):e212666. PMID: 35977180; PMCID: PMC8796904.
    Citations:    Translation:HumansCellsPHPublic Health
  29. Airewele EA, Sunpath H, Moosa MS, Gandhi RT. Importance of global communication to combat global pandemics: Lessons from the HIV Online Provider Education programme. South Afr J HIV Med. 2021; 22(1):1281. PMID: 34522431.
  30. McMahon DK, Zheng L, Cyktor JC, Aga E, Macatangay BJ, Godfrey C, Para M, Mitsuyasu RT, Hesselgesser J, Dragavon J, Dobrowolski C, Karn J, Acosta EP, Gandhi RT, Mellors JW. A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy. J Infect Dis. 2021 08 16; 224(4):648-656. PMID: 34398236; PMCID: PMC8366434.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  31. Rrapi R, Chand S, Lo JA, Gabel CK, Song S, Holcomb Z, Iriarte C, Moore K, Shi CR, Song H, Xia FD, Yanes D, Gandhi R, Triant VA, Kroshinsky D. The significance of exanthems in COVID-19 patients hospitalized at a tertiary care centre. J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e640-e642. PMID: 34146347; PMCID: PMC8447347.
    Citations:    Fields:    Translation:HumansCells
  32. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2. Ann Intern Med. 2021 07; 174(7):1037. PMID: 34280346.
    Citations: 1     Fields:    Translation:HumansCells
  33. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C. Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. Ann Intern Med. 2021 08; 174(8):1151-1158. PMID: 34125574; PMCID: PMC8252833.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  34. Triant VA, Gandhi RT. When Epidemics Collide: Why People With Human Immunodeficiency Virus May Have Worse Coronavirus Disease 2019 Outcomes and Implications for Vaccination. Clin Infect Dis. 2021 06 15; 72(12):e1030-e1034. PMID: 33395474.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  35. Enick PN, Brooker JP, Tumiotto CM, Staines BT, Eron JJ, McMahon DK, Gandhi RT, Mellors JW, Sobolewski MD. Comparison of methods to quantify inducible HIV-1 outgrowth. J Virus Erad. 2021 Jun; 7(2):100043. PMID: 34136266; PMCID: PMC8176359.
    Citations: 1     
  36. Siedner MJ, Gandhi RT. Proposing Minimum Requirements for Announcing Clinical Trial Results During the COVID-19 Pandemic. Clin Infect Dis. 2021 04 08; 72(7):1265-1267. PMID: 32640019; PMCID: PMC7454445.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  37. Rrapi R, Chand S, Lo JA, Gabel CK, Song S, Holcomb Z, Iriarte C, Moore K, Shi CR, Song H, Di Xia F, Yanes D, Gandhi R, Triant VA, Kroshinsky D. The significance of pressure injuries and purpura in COVID-19 patients hospitalized at a large urban academic medical center: A retrospective cohort study. J Am Acad Dermatol. 2021 08; 85(2):462-464. PMID: 33753253; PMCID: PMC7979268.
    Citations:    Fields:    Translation:HumansCells
  38. Saag MS, Gandhi RT, Sax PE. Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply. JAMA. 2021 03 02; 325(9):889-890. PMID: 33651088.
    Citations:    Fields:    Translation:Humans
  39. Diepstra KL, Barr L, Palm D, Hogg E, Mollan KR, Henley L, Stover AM, Simoni JM, Sugarman J, Brown B, Sauceda JA, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ, Dubé K. Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 2021 06; 37(6):489-501. PMID: 33472545; PMCID: PMC8213012.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  40. Li JZ, Gandhi RT. The Search for an HIV Cure: Where Do We Go From Here? J Infect Dis. 2021 02 15; 223(12 Suppl 2):1-3. PMID: 33586774; PMCID: PMC7883020.
    Citations: 1     Fields:    Translation:HumansCells
  41. Cyktor JC, Bosch RJ, Mar H, Macatangay BJ, Collier AC, Hogg E, Godfrey C, Eron JJ, McMahon DK, Mellors JW, Gandhi RT. Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy. J Infect Dis. 2021 02 13; 223(3):462-470. PMID: 32603416; PMCID: PMC7881329.
    Citations: 1     Fields:    Translation:HumansCells
  42. Stevenson EM, Ward AR, Truong R, Thomas AS, Huang SH, Dilling TR, Terry S, Bui JK, Mota TM, Danesh A, Lee GQ, Gramatica A, Khadka P, Alberto WDC, Gandhi RT, McMahon DK, Lalama CM, Bosch RJ, Macatangay B, Cyktor JC, Eron JJ, Mellors JW, Jones RB. HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy. JCI Insight. 2021 02 08; 6(3). PMID: 33400687.
    Citations: 11     Fields:    Translation:HumansCells
  43. Gandhi RT, Cyktor JC, Bosch RJ, Mar H, Laird GM, Martin A, Collier AC, Riddler SA, Macatangay BJ, Rinaldo CR, Eron JJ, Siliciano JD, McMahon DK, Mellors JW. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy. J Infect Dis. 2021 02 03; 223(2):225-233. PMID: 32823274; PMCID: PMC7857155.
    Citations: 24     Fields:    Translation:HumansCells
  44. McMahon DK, Zheng L, Cyktor JC, Aga E, Macatangay BJ, Godfrey C, Para M, Mitsuyasu RT, Hesselgesser J, Dragavon J, Dobrowolski C, Karn J, Acosta EP, Gandhi RT, Mellors JW. A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315). J Infect Dis. 2020 Dec 22. PMID: 33349862.
    Citations: 7     Fields:    
  45. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020 10 27; 324(16):1651-1669. PMID: 33052386.
    Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
  46. Meyerowitz EA, Kim AY, Ard KL, Basgoz N, Chu JT, Hurtado RM, Lee CK, He W, Minukas T, Nelson S, Ojikutu BO, Robbins G, Sanchez S, Triant VA, Zachary K, Gandhi RT. Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV. AIDS. 2020 10 01; 34(12):1781-1787. PMID: 32604138; PMCID: PMC7499878.
    Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
  47. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med. 2021 01; 174(1):69-79. PMID: 32941052; PMCID: PMC7505025.
    Citations: 209     Fields:    Translation:HumansCellsPHPublic Health
  48. Siedner MJ, Gandhi RT, Kim AY. Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic. J Infect Dis. 2020 09 01; 222(7):1084-1085. PMID: 32315424; PMCID: PMC7188169.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  49. Gottlieb GS, Rosenberg JM, Gonzalez RG, Gandhi RT. Case 27-2020: A 53-Year-Old Woman with Headache and Gait Imbalance. N Engl J Med. 2020 Aug 27; 383(9):859-866. PMID: 32846066.
    Citations:    Fields:    Translation:HumansCells
  50. Simonetti FR, White JA, Tumiotto C, Ritter KD, Cai M, Gandhi RT, Deeks SG, Howell BJ, Montaner LJ, Blankson JN, Martin A, Laird GM, Siliciano RF, Mellors JW, Siliciano JD. Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA. Proc Natl Acad Sci U S A. 2020 08 04; 117(31):18692-18700. PMID: 32690683.
    Citations: 23     Fields:    Translation:HumansCells
  51. Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27. PMID: 32338708.
    Citations: 331     Fields:    
  52. Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med. 2020 10 29; 383(18):1757-1766. PMID: 32329974.
    Citations: 431     Fields:    Translation:HumansCellsPHPublic Health
  53. Gandhi RT, Tashima KT, Smeaton LM, Vu V, Ritz J, Andrade A, Eron JJ, Hogg E, Fichtenbaum CJ. Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS). J Infect Dis. 2020 04 07; 221(9):1407-1415. PMID: 31135883; PMCID: PMC7137888.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  54. Dubé K, Hosey L, Starr K, Barr L, Evans D, Hoffman E, Campbell DM, Simoni J, Sugarman J, Sauceda J, Brown B, Diepstra KL, Godfrey C, Kuritzkes DR, Wohl DA, Gandhi R, Scully E. Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366. AIDS Res Hum Retroviruses. 2020 04; 36(4):268-282. PMID: 32160755; PMCID: PMC7185351.
    Citations: 14     Fields:    Translation:Humans
  55. Macatangay BJC, Gandhi RT, Jones RB, Mcmahon DK, Lalama CM, Bosch RJ, Cyktor JC, Thomas AS, Borowski L, Riddler SA, Hogg E, Stevenson E, Eron JJ, Mellors JW, Rinaldo CR. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy. AIDS. 2020 01 01; 34(1):15-24. PMID: 31634201; PMCID: PMC7313719.
    Citations: 10     Fields:    Translation:HumansCells
  56. Le CN, Britto P, Brummel SS, Hoffman RM, Li JZ, Flynn PM, Taha TE, Coletti A, Fowler MG, Bosch RJ, Gandhi RT, Klingman KL, McIntyre JA, Currier JS. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 2019 11 15; 33(14):2149-2156. PMID: 31373919; PMCID: PMC6832824.
    Citations: 5     Fields:    Translation:HumansCells
  57. Bedimo RJ, Mar H, Bosch RJ, Drechsler H, Cyktor JC, Macatangay BJC, Lalama C, Rinaldo C, Collier A, Godfrey C, Hogg E, Hensel C, Eron JJ, Mcmahon DK, Mellors JW, Tebas P, Gandhi RT. Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):e27-e31. PMID: 31335587; PMCID: PMC6799994.
    Citations: 6     Fields:    Translation:Humans
  58. Keating SM, Jones RB, Lalama CM, Bosch RJ, McMahon D, Hampton D, Cyktor J, Eron JJ, Mellors JW, Busch MP, Gandhi RT. Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):594-599. PMID: 31045647; PMCID: PMC6625873.
    Citations: 5     Fields:    Translation:HumansCells
  59. Spudich S, Robertson KR, Bosch RJ, Gandhi RT, Cyktor JC, Mar H, Macatangay BJ, Lalama CM, Rinaldo C, Collier AC, Godfrey C, Eron JJ, McMahon D, Jacobs JL, Koontz D, Hogg E, Vecchio A, Mellors JW. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance. J Clin Invest. 2019 07 15; 129(8):3339-3346. PMID: 31305262; PMCID: PMC6668666.
    Citations: 33     Fields:    Translation:HumansCellsCTClinical Trials
  60. Wojciechowski D, Gandhi RT, Rosales IA. Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease. N Engl J Med. 2019 Apr 11; 380(15):1464-1472. PMID: 30970193.
    Citations:    Fields:    Translation:HumansCells
  61. Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, Colby DJ, Dawson L, Dong KL, Dubé K, Eron J, Frater J, Gandhi RT, Geleziunas R, Goulder P, Hanna GJ, Jefferys R, Johnston R, Kuritzkes D, Li JZ, Likhitwonnawut U, van Lunzen J, Martinez-Picado J, Miller V, Montaner LJ, Nixon DF, Palm D, Pantaleo G, Peay H, Persaud D, Salzwedel J, Salzwedel K, Schacker T, Sheikh V, Søgaard OS, Spudich S, Stephenson K, Sugarman J, Taylor J, Tebas P, Tiemessen CT, Tressler R, Weiss CD, Zheng L, Robb ML, Michael NL, Mellors JW, Deeks SG, Walker BD. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. Lancet HIV. 2019 04; 6(4):e259-e268. PMID: 30885693; PMCID: PMC6688772.
    Citations: 80     Fields:    Translation:Humans
  62. Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963. PMID: 30085241; PMCID: PMC6217727.
    Citations: 68     Fields:    Translation:HumansCells
  63. Jilg N, Hunt PW, Gandhi RT. HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study. AIDS. 2018 09 24; 32(15):2255-2257. PMID: 30212405; PMCID: PMC6505463.
    Citations: 1     Fields:    Translation:HumansCells
  64. Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E. Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex. Int J Syst Evol Microbiol. 2018 Nov; 68(11):3557-3562. PMID: 30204586; PMCID: PMC6607433.
    Citations: 4     Fields:    Translation:HumansCells
  65. Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018 08 31; 128(9):4074-4085. PMID: 30024859; PMCID: PMC6118642.
    Citations: 38     Fields:    Translation:HumansCells
  66. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396. PMID: 30043070; PMCID: PMC6415748.
    Citations: 207     Fields:    Translation:Humans
  67. Gandhi M, Gandhi RT, Stefanescu A, Bosch RJ, Cyktor JC, Horng H, Louie A, Phung N, Eron JJ, Hogg E, Macatangay BJC, Hensel C, Fletcher CV, Mellors JW, McMahon DK. Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART. J Infect Dis. 2018 06 20; 218(2):234-238. PMID: 29529230; PMCID: PMC6009579.
    Citations: 12     Fields:    Translation:HumansCells
  68. Singh N, Robinson RD, Duane TM, Kirby JJ, Lyell C, Buca S, Gandhi R, Mann SM, Zenarosa NR, Wang H. Role of ED crowding relative to trauma quality care in a Level 1 Trauma Center. Am J Emerg Med. 2019 04; 37(4):579-584. PMID: 30139579.
    Citations: 2     Fields:    Translation:Humans
  69. Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA. J Virol. 2018 06 15; 92(12). PMID: 29593048.
    Citations: 17     Fields:    Translation:HumansCells
  70. Ard KL, Kelly HR, Gandhi RT, Louissaint A. Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face. N Engl J Med. 2018 Mar 22; 378(12):1143-1152. PMID: 29562158.
    Citations: 2     Fields:    Translation:HumansCells
  71. Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine. 2018 01 25; 36(4):453-460. PMID: 29254840; PMCID: PMC5767517.
    Citations: 8     Fields:    Translation:Humans
  72. Park YJ, Etemad B, Ahmed H, Naranbhai V, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Para M, Gandhi RT, Carrington M, Li JZ. Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption. Pathog Immun. 2017; 2(3):431-445. PMID: 29333522; PMCID: PMC5761077.
    Citations: 4     
  73. Thomas AS, Jones KL, Gandhi RT, McMahon DK, Cyktor JC, Chan D, Huang SH, Truong R, Bosque A, Macedo AB, Kovacs C, Benko E, Eron JJ, Bosch RJ, Lalama CM, Simmens S, Walker BD, Mellors JW, Jones RB. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy. PLoS Pathog. 2017 Sep; 13(9):e1006629. PMID: 28931091.
    Citations: 19     Fields:    Translation:HumansCells
  74. Siedner MJ, Bwana MB, Moosa MS, Paul M, Pillay S, McCluskey S, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson B, Gandhi RT, Sunpath H, Marconi VC. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates. HIV Clin Trials. 2017 07; 18(4):149-155. PMID: 28720039.
    Citations: 9     Fields:    Translation:HumansCells
  75. Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy. J Infect Dis. 2017 07 15; 216(2):254-262. PMID: 28838149; PMCID: PMC5853412.
    Citations: 22     Fields:    Translation:HumansCells
  76. Mukerji SS, Gonzalez RG, Gandhi RT, Kraft S. Case 20-2017 - A 48-Year-Old Man with Weight Loss, Confusion, Skin Lesions, and Pancytopenia. N Engl J Med. 2017 06 29; 376(26):2580-2589. PMID: 28657866; PMCID: PMC9165433.
    Citations:    Fields:    Translation:HumansCells
  77. Gandhi RT, McMahon DK, Bosch RJ, Lalama CM, Cyktor JC, Macatangay BJ, Rinaldo CR, Riddler SA, Hogg E, Godfrey C, Collier AC, Eron JJ, Mellors JW. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog. 2017 Apr; 13(4):e1006285. PMID: 28426825; PMCID: PMC5398724.
    Citations: 79     Fields:    Translation:HumansCells
  78. Adelman MW, Johnson JH, Hohmann EL, Gandhi RT. Ovarian Endometrioma Superinfected With Salmonella: Case Report and Review of the Literature. Open Forum Infect Dis. 2017; 4(2):ofx048. PMID: 28470024; PMCID: PMC5407207.
    Citations: 4     
  79. Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016 Jul 12; 316(2):191-210. PMID: 27404187; PMCID: PMC5012643.
    Citations: 226     Fields:    Translation:HumansCellsPHPublic Health
  80. Treasure GC, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Para M, Gandhi RT, Li JZ. Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):310-3. PMID: 26910502; PMCID: PMC4911279.
    Citations: 9     Fields:    Translation:HumansCells
  81. Gandhi RT, Kwon DS, Macklin EA, Shopis JR, McLean AP, McBrine N, Flynn T, Peter L, Sbrolla A, Kaufmann DE, Porichis F, Walker BD, Bhardwaj N, Barouch DH, Kavanagh DG. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. J Acquir Immune Defic Syndr. 2016 Mar 01; 71(3):246-53. PMID: 26379068; PMCID: PMC4752409.
    Citations: 40     Fields:    Translation:HumansCellsPHPublic Health
  82. Li JZ, Etemad B, Ahmed H, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Lederman MM, Para M, Gandhi RT. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 2016 Jan 28; 30(3):343-53. PMID: 26588174; PMCID: PMC4840470.
    Citations: 143     Fields:    Translation:HumansCells
  83. Tashima KT, Smeaton LM, Fichtenbaum CJ, Andrade A, Eron JJ, Gandhi RT, Johnson VA, Klingman KL, Ritz J, Hodder S, Santana JL, Wilkin T, Haubrich RH. HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial. Ann Intern Med. 2015 Dec 15; 163(12):908-17. PMID: 26595748; PMCID: PMC4681296.
    Citations: 6     Fields:    Translation:HumansCells
  84. Kearney MF, Wiegand A, Shao W, Coffin JM, Mellors JW, Lederman M, Gandhi RT, Keele BF, Li JZ. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy. J Virol. 2016 02 01; 90(3):1369-76. PMID: 26581989.
    Citations: 77     Fields:    Translation:HumansCells
  85. Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS. 2015 Oct 23; 29(16):2121-9. PMID: 26544577; PMCID: PMC4638139.
    Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
  86. Gandhi RT, Bosch RJ, Rangsin R, Chuenchitra T, Sirisopana N, Kim JH, Robb ML, Vejbaesya S, Paris RM, Nelson KE. HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):44-9. PMID: 26383907; PMCID: PMC4692108.
    Citations: 4     Fields:    Translation:HumansCells
  87. Riddler SA, Aga E, Bosch RJ, Bastow B, Bedison M, Vagratian D, Vaida F, Eron JJ, Gandhi RT, Mellors JW. Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy. J Infect Dis. 2016 Feb 15; 213(4):556-60. PMID: 26333941; PMCID: PMC4721905.
    Citations: 29     Fields:    Translation:HumansCells
  88. Tashima KT, Mollan KR, Na L, Gandhi RT, Klingman KL, Fichtenbaum CJ, Andrade A, Johnson VA, Eron JJ, Smeaton L, Haubrich RH. Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity. HIV Clin Trials. 2015 08; 16(4):147-56. PMID: 26212575; PMCID: PMC4640927.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  89. Ouyang Z, Buzon MJ, Zheng L, Sun H, Yu XG, Bosch RJ, Mellors JW, Eron JJ, Gandhi RT, Lichterfeld M. Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir. Open Forum Infect Dis. 2015 Apr; 2(2):ofv045. PMID: 26380343; PMCID: PMC4567091.
    Citations: 1     
  90. Gandhi RT, Alkasab TK, Nardi V, Branda JA. Case records of the Massachusetts General Hospital. Case 40-2014. A 57-year-old man with inguinal pain, lymphadenopathy, and HIV infection. N Engl J Med. 2014 Dec 25; 371(26):2511-20. PMID: 25539108.
    Citations:    Fields:    Translation:HumansCells
  91. Gandhi M, Gandhi RT. Single-pill regimens for HIV-1 infection. N Engl J Med. 2014 11 06; 371(19):1845-6. PMID: 25372099.
    Citations: 1     Fields:    Translation:HumansCells
  92. Zheng L, Taiwo B, Gandhi RT, Hunt PW, Collier AC, Flexner C, Bosch RJ. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):153-60. PMID: 25072610; PMCID: PMC4167746.
    Citations: 16     Fields:    Translation:HumansCells
  93. Simner PJ, Hyle EP, Buckwalter SP, Branda JA, Brown-Elliott BA, Franklin J, Toney NC, de Man TJ, Wallace RJ, Vasireddy R, Gandhi RT, Wengenack NL. Tenosynovitis caused by a novel nontuberculous Mycobacterium species initially misidentified as a member of the Mycobacterium tuberculosis complex. J Clin Microbiol. 2014 Dec; 52(12):4414-8. PMID: 25253791.
    Citations: 3     Fields:    Translation:HumansCells
  94. Zanoni BC, Gandhi RT. Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am. 2014 Sep; 28(3):501-18. PMID: 25151568.
    Citations: 11     Fields:    Translation:Humans
  95. Chan J, Gandhi RT. A Case of Septic Arthritis of the Shoulder Due to Yersinia enterocolitica with Review of the Literature. Open Forum Infect Dis. 2014 Sep; 1(2):ofu054. PMID: 25734124; PMCID: PMC4281793.
    Citations: 2     
  96. Besson GJ, Lalama CM, Bosch RJ, Gandhi RT, Bedison MA, Aga E, Riddler SA, McMahon DK, Hong F, Mellors JW. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clin Infect Dis. 2014 Nov 01; 59(9):1312-21. PMID: 25073894.
    Citations: 125     Fields:    Translation:HumansCellsCTClinical Trials
  97. Gandhi M, Gandhi RT. Single-pill combination regimens for treatment of HIV-1 infection. N Engl J Med. 2014 Jul 17; 371(3):248-59. PMID: 25014689.
    Citations: 22     Fields:    Translation:HumansCells
  98. Sandler NG, Zhang X, Bosch RJ, Funderburg NT, Choi AI, Robinson JK, Fine DM, Coombs RW, Jacobson JM, Landay AL, Douek DC, Tressler R, Read SW, Wilson CC, Deeks SG, Lederman MM, Gandhi RT. Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. J Infect Dis. 2014 Nov 15; 210(10):1549-54. PMID: 24864123; PMCID: PMC4215074.
    Citations: 45     Fields:    Translation:HumansCTClinical Trials
  99. Li JZ, Gandhi RT. The sooner, the better: more evidence that early antiretroviral therapy lowers viral reservoirs in HIV-infected infants. J Infect Dis. 2014 Nov 15; 210(10):1519-22. PMID: 24850791.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  100. Jost S, Tomezsko PJ, Rands K, Toth I, Lichterfeld M, Gandhi RT, Altfeld M. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination. J Virol. 2014 Aug; 88(15):8349-54. PMID: 24829350.
    Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
  101. Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H. Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa. PLoS One. 2013; 8(12). PMID: 29220839.
    Citations: 1     Fields:    
  102. Friedland GH, Naidoo P, Abdool-Gafoor B, Moosa MY, Ramdial PK, Gandhi RT. Case records of the Massachusetts General Hospital. Case 29-2013. A 32-year-old HIV-positive African man with dyspnea and skin lesions. N Engl J Med. 2013 Sep 19; 369(12):1152-61. PMID: 24047065.
    Citations: 2     Fields:    Translation:HumansCells
  103. Hyle EP, Wood BR, Backman ES, Noubary F, Hwang J, Lu Z, Losina E, Walensky RP, Gandhi RT. High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):602-8. PMID: 23714741; PMCID: PMC3805773.
    Citations: 4     Fields:    Translation:Humans
  104. Henrich TJ, Gandhi RT. Early treatment and HIV-1 reservoirs: a stitch in time? J Infect Dis. 2013 Oct 15; 208(8):1189-93. PMID: 23852126; PMCID: PMC3778963.
    Citations: 10     Fields:    Translation:HumansCells
  105. Taiwo B, Hunt PW, Gandhi RT, Ellingson A, McKenna M, Jacobson JM, Gripshover B, Bosch RJ. CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy. J Acquir Immune Defic Syndr. 2013 May 01; 63(1):101-4. PMID: 23392463; PMCID: PMC3632289.
    Citations: 13     Fields:    Translation:HumansCells
  106. Ruiz-Riol M, Mothe B, Gandhi RT, Bhardwaj N, Scadden DT, Sanchez-Merino V, Brander C. Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patients. Eur J Immunol. 2013 Jun; 43(6):1545-54. PMID: 23504637.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  107. Gandhi RT, Bosch RJ, Aga E, Bedison MA, Bastow B, Schmitz JL, Siliciano JD, Siliciano RF, Eron JJ, Mellors JW. Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173. Antivir Ther. 2013; 18(4):607-13. PMID: 23411421.
    Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
  108. Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H. Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa. PLoS One. 2012; 7(9):e44793. PMID: 23028623.
    Citations: 14     Fields:    Translation:HumansCells
  109. Deeks SG, Gandhi RT, Chae CU, Lewandrowski KB. Case records of the Massachusetts General Hospital. Case 30-2012. A 54-year-old woman with HIV infection, dyspnea, and chest pain. N Engl J Med. 2012 Sep 27; 367(13):1246-54. PMID: 23013077.
    Citations: 1     Fields:    Translation:Humans
  110. Zheng L, Bosch RJ, Chan ES, Read S, Kearney M, Margolis DM, Mellors JW, Eron JJ, Gandhi RT. Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy. Antivir Ther. 2013; 18(1):39-43. PMID: 22914318.
    Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
  111. Wilkin TJ, Lalama CM, McKinnon J, Gandhi RT, Lin N, Landay A, Ribaudo H, Fox L, Currier JS, Mellors JW, Gulick R, Tenorio AR. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012 Aug 15; 206(4):534-42. PMID: 22740718; PMCID: PMC3491731.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
  112. Gandhi RT, Sax PE, Grinspoon SK. Metabolic and cardiovascular complications in HIV-infected patients: new challenges for a new age. J Infect Dis. 2012 Jun; 205 Suppl 3:S353-4. PMID: 22577207; PMCID: PMC3349297.
    Citations: 11     Fields:    Translation:Humans
  113. Gandhi RT, Coombs RW, Chan ES, Bosch RJ, Zheng L, Margolis DM, Read S, Kallungal B, Chang M, Goecker EA, Wiegand A, Kearney M, Jacobson JM, D'Aquila R, Lederman MM, Mellors JW, Eron JJ. No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr. 2012 Mar 01; 59(3):229-35. PMID: 22083073; PMCID: PMC3423091.
    Citations: 66     Fields:    Translation:HumansCells
  114. Gandhi RT, Deeks SG. Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough? Clin Infect Dis. 2012 Mar 01; 54(5):733-5. PMID: 22238162.
    Citations: 7     Fields:    Translation:HumansCells
  115. Lichterfeld M, Gandhi RT, Simmons RP, Flynn T, Sbrolla A, Yu XG, Basgoz N, Mui S, Williams K, Streeck H, Burgett-Yandow N, Roy G, Janssens M, Pedneault L, Vandepapelière P, Koutsoukos M, Demoitié MA, Bourguignon P, McNally L, Voss G, Altfeld M. Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. J Acquir Immune Defic Syndr. 2012 Jan 01; 59(1):1-9. PMID: 21963936; PMCID: PMC3241906.
    Citations: 8     Fields:    Translation:HumansCells
  116. Coleman SM, Blashill AJ, Gandhi RT, Safren SA, Freudenreich O. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics. 2012 Jan-Feb; 53(1):51-7. PMID: 22221721.
    Citations: 9     Fields:    Translation:Humans
  117. Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, Berger JR, Ngo L, Koralnik IJ. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011 Jul; 85(14):7256-63. PMID: 21543472.
    Citations: 62     Fields:    Translation:HumansCells
  118. Matthews LT, Giddy J, Ghebremichael M, Hampton J, Guarino AJ, Ewusi A, Carver E, Axten K, Geary MC, Gandhi RT, Bangsberg DR. A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. PLoS One. 2011 Apr 11; 6(4):e18736. PMID: 21494566.
    Citations: 8     Fields:    Translation:HumansCells
  119. Campbell-Yesufu OT, Gandhi RT. Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis. 2011 Mar 15; 52(6):780-7. PMID: 21367732.
    Citations: 70     Fields:    Translation:HumansCells
  120. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. PMID: 21051598; PMCID: PMC3235490.
    Citations: 654     Fields:    Translation:HumansCells
  121. Gandhi RT, Zheng L, Bosch RJ, Chan ES, Margolis DM, Read S, Kallungal B, Palmer S, Medvik K, Lederman MM, Alatrakchi N, Jacobson JM, Wiegand A, Kearney M, Coffin JM, Mellors JW, Eron JJ. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med. 2010 Aug 10; 7(8). PMID: 20711481.
    Citations: 170     Fields:    Translation:HumansCells
  122. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, Rodriguez BA, Pollard RB, Lederman MM, Landay A. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis. 2010 Jun 15; 201(12):1796-805. PMID: 20446847; PMCID: PMC2873127.
    Citations: 92     Fields:    Translation:HumansCells
  123. Gandhi RT. Report from the 17th Conference on Retroviruses and Opportunistic Infections. HCV/HIV coinfection: translating new discoveries into clinical practice. J Watch AIDS Clin Care. 2010 Apr; 22(4):34. PMID: 20480622.
    Citations:    Fields:    Translation:Humans
  124. Gandhi RT, Bosch RJ, Aga E, Albrecht M, Demeter LM, Dykes C, Bastow B, Para M, Lai J, Siliciano RF, Siliciano JD, Eron JJ. No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy. J Infect Dis. 2010 Jan 15; 201(2):293-6. PMID: 20001856; PMCID: PMC2887684.
    Citations: 47     Fields:    Translation:HumansCellsCTClinical Trials
  125. Nejad SH, Gandhi RT, Freudenreich O. Clozapine use in HIV-infected schizophrenia patients: a case-based discussion and review. Psychosomatics. 2009 Nov-Dec; 50(6):626-32. PMID: 19996235.
    Citations: 2     Fields:    Translation:Humans
  126. Taylor CR, Gandhi RT, Handwerker J, Duncan LM. Case records of the Massachusetts General Hospital. Case 34-2009. A 20-year-old man with sore throat, fever, and rash. N Engl J Med. 2009 Oct 29; 361(18):1787-96. PMID: 19864678.
    Citations:    Fields:    Translation:HumansCells
  127. Paddison J, Fricchione G, Gandhi RT, Freudenreich O. Fatigue in psychiatric HIV patients: a pilot study of psychological correlates. Psychosomatics. 2009 Sep-Oct; 50(5):455-60. PMID: 19855030.
    Citations: 6     Fields:    Translation:Humans
  128. Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ. Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Res Hum Retroviruses. 2009 Aug; 25(8):795-802. PMID: 19678765; PMCID: PMC2827835.
    Citations: 19     Fields:    Translation:HumansCells
  129. Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, Schlesinger SJ, Marovich MA, Bhardwaj N, Jacobson JM. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 2009 Oct 09; 27(43):6088-94. PMID: 19450647; PMCID: PMC2820102.
    Citations: 39     Fields:    Translation:HumansCellsCTClinical Trials
  130. Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr. 2009 Mar 01; 50(3):250-8. PMID: 19194319; PMCID: PMC3482469.
    Citations: 2     Fields:    Translation:HumansCells
  131. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009 Feb 01; 48(3):350-61. PMID: 19123865.
    Citations: 119     Fields:    Translation:HumansCells
  132. Bloom A, Jackson K, Kiviat A, Zheng H, Sax P, Gandhi R. Repeat hepatitis B vaccination may lead to seroprotection in HIV-infected patients who do not respond to an initial series. J Acquir Immune Defic Syndr. 2009 Jan 01; 50(1):110-3. PMID: 19092450.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  133. Marzocchetti A, Lima M, Tompkins T, Kavanagh DG, Gandhi RT, O'Neill DW, Bhardwaj N, Koralnik IJ. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology. 2009 Jan 20; 383(2):173-7. PMID: 19062062.
    Citations: 15     Fields:    Translation:HumansCells
  134. Minkis K, Kavanagh DG, Alter G, Bogunovic D, O'Neill D, Adams S, Pavlick A, Walker BD, Brockman MA, Gandhi RT, Bhardwaj N. Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Res. 2008 Nov 15; 68(22):9441-50. PMID: 19010919; PMCID: PMC2628575.
    Citations: 21     Fields:    Translation:HumansCells
  135. Ngumbela KC, Ryan KP, Sivamurthy R, Brockman MA, Gandhi RT, Bhardwaj N, Kavanagh DG. Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells. PLoS One. 2008 Jun 04; 3(6):e2356. PMID: 18523584.
    Citations: 25     Fields:    Translation:HumansCells
  136. Gandhi RT. Report from the 15th Retrovirus Conference. HIV/HCV: good news, continued challenges. AIDS Clin Care. 2008 Apr; 20(4):32. PMID: 19266670.
    Citations:    Fields:    Translation:Humans
  137. Gandhi RT. Raltegravir, a new HIV integrase inhibitor. AIDS Clin Care. 2007 Dec; 19(12):105. PMID: 18399003.
    Citations: 2     Fields:    Translation:Humans
  138. Kiviat AD, Geary MC, Sunpath H, Moosa MY, Wilson D, Narasimhan P, Gandhi RT. HIV Online Provider Education (HOPE): the internet as a tool for training in HIV medicine. J Infect Dis. 2007 Dec 01; 196 Suppl 3:S512-5. PMID: 18181703.
    Citations: 11     Fields:    Translation:HumansCells
  139. Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT. Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis. 2007 Dec 01; 196 Suppl 3:S449-56. PMID: 18181693.
    Citations: 30     Fields:    Translation:Humans
  140. Lichterfeld M, Kavanagh DG, Williams KL, Moza B, Mui SK, Miura T, Sivamurthy R, Allgaier R, Pereyra F, Trocha A, Feeney M, Gandhi RT, Rosenberg ES, Altfeld M, Allen TM, Allen R, Walker BD, Sundberg EJ, Yu XG. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007 Nov 26; 204(12):2813-24. PMID: 18025130.
    Citations: 56     Fields:    Translation:HumansCells
  141. McGovern BH, Birch C, Zaman MT, Bica I, Stone D, Quirk JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, Gandhi RT. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis. 2007 Nov 15; 45(10):1386-92. PMID: 17968840.
    Citations: 2     Fields:    Translation:HumansCells
  142. Freudenreich O, Gandhi RT, Walsh JP, Henderson DC, Goff DC. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort. Psychosomatics. 2007 Sep-Oct; 48(5):405-11. PMID: 17878499.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  143. Addo MM, Draenert R, Rathod A, Verrill CL, Davis BT, Gandhi RT, Robbins GK, Basgoz NO, Stone DR, Cohen DE, Johnston MN, Flynn T, Wurcel AG, Rosenberg ES, Altfeld M, Walker BD. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One. 2007 Mar 28; 2(3):e321. PMID: 17389912.
    Citations: 53     Fields:    Translation:HumansCells
  144. Lima MA, Marzocchetti A, Autissier P, Tompkins T, Chen Y, Gordon J, Clifford DB, Gandhi RT, Venna N, Berger JR, Koralnik IJ. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol. 2007 Apr; 81(7):3361-8. PMID: 17229701; PMCID: PMC1866063.
    Citations: 27     Fields:    Translation:HumansCells
  145. Gandhi RT. Cirrhosis is associated with low CD4+ T cell counts: implications for HIV-infected patients with liver disease. Clin Infect Dis. 2007 Feb 01; 44(3):438-40. PMID: 17205455.
    Citations: 4     Fields:    Translation:HumansCells
  146. Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, Duncan JE, Jones AM, Wurcel AG, Davis BT, Gandhi RT, Robbins GK, Allen TM, Chung RT, Lauer GM, Walker BD. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 2006 Dec; 3(12):e492. PMID: 17194190; PMCID: PMC1705826.
    Citations: 38     Fields:    Translation:HumansCells
  147. Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, Hirsch MS, Shafer RW, Robbins GK, Pollard RB. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006 Aug 01; 42(4):426-34. PMID: 16810109.
    Citations: 88     Fields:    Translation:Humans
  148. McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006 Aug 01; 43(3):365-72. PMID: 16804853.
    Citations: 40     Fields:    Translation:HumansCells
  149. Lauer GM, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Schulze Zur Wiesch J, Paranhos-Baccala G, Sheridan I, Casson DR, Reiser M, Gandhi RT, Li B, Allen TM, Chung RT, Klenerman P, Walker BD. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol. 2005 Oct; 79(20):12979-88. PMID: 16189000; PMCID: PMC1235828.
    Citations: 41     Fields:    Translation:HumansCells
  150. Gandhi RT, Altfeld M. The quest for an HIV-1 therapeutic vaccine. J Infect Dis. 2005 Aug 15; 192(4):556-9. PMID: 16028123.
    Citations: 2     Fields:    Translation:HumansCells
  151. Gandhi RT. Guideline watch. New guidelines on treating chronic hepatitis B and C in HIV-coinfected patients. AIDS Clin Care. 2005 Jul; 17(7):65. PMID: 16110574.
    Citations:    Fields:    Translation:Humans
  152. Koziel M, Gandhi RT. Antiretroviral rounds. Three diseases, one patient. AIDS Clin Care. 2005 May; 17(5):50-1. PMID: 15929207.
    Citations:    Fields:    Translation:Humans
  153. Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis. 2005 May 01; 191(9):1435-41. PMID: 15809901.
    Citations: 34     Fields:    Translation:Humans
  154. Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Schulze zur Wiesch J, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, Allen TM. CD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004 Dec 20; 200(12):1593-604. PMID: 15611288; PMCID: PMC2212005.
    Citations: 139     Fields:    Translation:HumansAnimalsCells
  155. Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KA. A therapeutic HIV vaccine: how good is good enough? Vaccine. 2004 Sep 28; 22(29-30):4044-53. PMID: 15364455.
    Citations: 7     Fields:    Translation:Humans
  156. Boyle BA, Gandhi RT. When CD4-cell count is nearly as undetectable as the viral load. AIDS Clin Care. 2004 Jun; 16(6):48-9. PMID: 15241849.
    Citations:    Fields:    Translation:Humans
  157. Gandhi RT, Wurcel A, McGovern B, Lee H, Shopis J, Corcoran CP, Toner S, Giachetti C, Dockter J, Sax PE, Ukomadu C. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr. 2003 Dec 01; 34(4):439-41. PMID: 14615664.
    Citations: 10     Fields:    Translation:HumansCells
  158. Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis. 2003 Dec 15; 37(12):1693-8. PMID: 14689353.
    Citations: 39     Fields:    Translation:HumansCells
  159. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis. 2003 Jun 15; 36(12):1602-5. PMID: 12802762.
    Citations: 27     Fields:    Translation:HumansCells
  160. Gandhi RT. Immune-based therapy in HIV. Hopkins HIV Rep. 2003 Mar; 15(2):4. PMID: 12739500.
    Citations:    Fields:    Translation:Humans
  161. Johnson JR, Gandhi R. Case 28-2002: a traveler with a rapidly progressive soft-tissue infection. N Engl J Med. 2003 Jan 09; 348(2):176-7; author reply 176-7. PMID: 12519934.
    Citations:    Fields:    Translation:HumansCells
  162. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BD. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol. 2002 Dec; 76(24):12584-95. PMID: 12438584; PMCID: PMC136690.
    Citations: 86     Fields:    Translation:HumansCells
  163. Erbelding EJ, Lucas GM, Gandhi RT. HIV notes from the 40th annual meeting of the Infectious Diseases Society of America. Hopkins HIV Rep. 2002 Nov; 14(6):6-7. PMID: 12491991.
    Citations:    Fields:    Translation:Humans
  164. Gandhi RT, Walker BD. Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection. Curr Opin Immunol. 2002 Aug; 14(4):487-94. PMID: 12088684.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  165. Gandhi RT, Walker BD. Immunologic control of HIV-1. Annu Rev Med. 2002; 53:149-72. PMID: 11818468.
    Citations: 51     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gandhi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (492)
Co-Authors (104)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.